Our Mission
Our mission is to revolutionize healthcare by innovation and proximity to patients. As pioneers in transcatheter minimally invasive technology, we are developing and delivering a breakthrough tricuspid heart valve replacement system that brings hope and improves quality of life for those in need. Our commitment to excellence drives us to create a product that proves safety and efficacy for patients, and ease of use for healthcare professionals.
TRiCares Team
We are growing as a team and are full of ideas – committed personalities with diverse skills and experiences. Bringing an innovative product to market and striving to making it the best possible is our daily approach.
Management
Helmut J.
Straubinger
President and CEO
- 30 years of experience in building medical device companies: C.R. Bard, Optimed Medizin Technik, Antox, Jena Valve
- Developed and brought the first European transcatheter aortic valve replacement (TAVR) system to the market in 2012 - JenaValve Technology, built subsidiary in US, realized sales of > € 10M within 2 years
- Track record in fund raising and successful deal-making in the medical device field
Esther
Gerteis
VP Medical & Regulatory Affairs
- More than 20 years experience in clinical research with Edwards Lifesciences, Biotronik VI and CorFlow Therapeutics
- Specialized in interventional cardiology, surgical and transcatheter heart valve therapy, heart failure and vascular intervention world wide in Europe, US, Asia
Investors
Scientific Advisory Board
- Eberhard Grube
- Hendrik Treede
- Neil Fam
- Nicolas van Miegem
- Pascal Lim
- Philipp Blanke
- Susheel Kodali
- Ulrich Schäfer
Career
We currently have no vacancies, but we are always happy to receive an unsolicited application!